CLINICAL_TRIALS
research
· 2013-12-12
Clinical Trial Update: Botulinum Toxin in the Treatment of Idiopathic Detrusor Overactivity [Phase 4]
Summary
Phase 4 clinical trial update evaluating botulinum toxin for idiopathic detrusor overactivity (overactive bladder).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mr HD Flood | Conditions: Overactive Detrusor | Phase 4 | Status: UNKNOWN